What the GP Visit Actually Looks Like — and Why It Falls Short
The typical UK male pattern hair loss GP consultation goes something like this: a 10-minute appointment, a visual assessment, confirmation that it is indeed androgenetic alopecia, and a recommendation to try Minoxidil — available over the counter, so no prescription required. If you're lucky, finasteride might be mentioned. A referral to NHS dermatology for hair loss is very rarely offered, and when it is, the waiting time frequently exceeds 18 weeks.
This is not a criticism of GPs. A 10-minute appointment is not enough time to explain the three mechanisms driving androgenetic alopecia, the evidence hierarchy for treatments, the role of combination therapy, the shedding phase, the window of reversibility, or why starting earlier rather than later changes outcomes significantly. The NHS system is not resourced for that consultation.
The result is that most UK men with early male pattern hair loss leave their GP appointment with a partial picture — and typically start Minoxidil alone, encounter the shedding phase, stop within 6 weeks, and conclude the treatment doesn't work. This cycle is the most expensive form of hair loss management there is. Years pass. The window narrows.
By age 30, approximately 30% of UK men show some degree of hair loss. By 50, it's 50%. The loss is progressive — each year without treatment, more follicles miniaturise past the point of reversibility. The men who get the best non-surgical outcomes are those who start at Norwood II, not Norwood IV. Your GP's "watchful waiting" recommendation is, for hair loss, a recommendation to let the window close.
What's Actually Causing It — The Three Mechanisms
Male pattern hair loss (androgenetic alopecia) is driven by three mechanisms operating simultaneously. Understanding this is the foundation for understanding why single-treatment monotherapy — what most GPs recommend — consistently underperforms.
1. DHT Sensitivity. Dihydrotestosterone (DHT) — derived from testosterone via the enzyme 5-alpha reductase — binds to androgen receptors in genetically susceptible follicles. Each binding event shortens the anagen (growth) phase slightly. Over years, this progressive miniaturisation produces the characteristic pattern of recession and thinning. This is the genetic mechanism that finasteride and dutasteride address by reducing DHT by 70–90%.
2. Scalp Microcirculation Deficit. Men with androgenetic alopecia consistently show significantly reduced scalp blood flow in affected areas compared to unaffected men — restricting oxygen and nutrient delivery to follicle papilla cells. This is the mechanism that Minoxidil, LLLT, and RF scalp stimulation target. Poor circulation starves follicles already stressed by DHT, accelerating the miniaturisation timeline.
3. Perifollicular Inflammation. Chronic low-grade inflammation around the follicle is consistently observed in androgenetic alopecia biopsies. This inflammation creates a hostile microenvironment that accelerates miniaturisation — and is the mechanism most consistently ignored by standard GP-prescribed treatments. RF and EMS scalp stimulation directly address this pathway.
A GP-prescribed course of Minoxidil addresses mechanism 2 (partly). Finasteride addresses mechanism 1. Neither addresses mechanism 3 (inflammation). This is why combination therapy — which the evidence now strongly supports — consistently outperforms monotherapy. The most effective non-surgical protocol requires all three mechanisms to be addressed simultaneously.
Deep Dive DHT, Circulation & Inflammation: Why You Need to Address All Three — Article 043 →The Norwood Scale — Where You Are and What It Means
The Norwood-Hamilton scale classifies male pattern hair loss in seven stages. Your stage determines both your treatment options and — critically — how much of the reversibility window you have left.
The highlighted stages (I–III) represent the window where non-surgical treatment is most effective — and where the majority of men who act early avoid the more dramatic loss their genetics would otherwise produce. By Norwood IV, you have already lost the best years of the reversibility window.
What the NHS Can and Cannot Do
- GP consultation and diagnosis
- Private prescription for finasteride (patient pays)
- Over-the-counter Minoxidil recommendation
- Blood tests to rule out reversible causes (thyroid, ferritin, vitamin D)
- NHS dermatology referral in complex cases (18+ week wait)
- Mental health support if hair loss is causing significant distress
- NHS-funded finasteride for cosmetic hair loss (NICE guidance)
- Surgical hair restoration on the NHS
- PRP therapy
- At-home device prescription or subsidy
- Combination protocol planning
- Fast-track dermatology for early-stage loss
- Ongoing monitoring of hair loss progression
The gap between what the NHS offers and what the evidence recommends is significant. NICE does not recommend NHS prescribing of finasteride for cosmetic hair loss — meaning the most effective pharmaceutical treatment requires either a private GP prescription (widely available, including via online prescribing services at £10–£30/month for generic finasteride) or out-of-pocket cost.
For most UK men under 40 with Norwood I–III hair loss, the NHS pathway provides a diagnosis and a starting point. The complete protocol requires going beyond it.
Related Finasteride Side Effects UK: Why Men Are Looking for Alternatives in 2025 — Article 030 →The Complete Non-Surgical Protocol — What the Evidence Actually Supports
The 2025 evidence base clearly favours combination therapy over monotherapy. Here is the complete protocol that addresses all three mechanisms simultaneously — designed around UK availability, NHS access points, and realistic cost.
The Real UK Cost of This Protocol
Compare this to: NHS dermatology referral wait of 18+ weeks (free but slow), private dermatology consultation (£150–£300 for initial appointment), PRP therapy (£300–£800 per session, 3–6 sessions needed), or hair transplant (£3,000–£12,000+). The complete non-surgical combination protocol costs £64–£119 per month and addresses more mechanisms simultaneously than any clinical single-treatment alternative at significantly lower cost.
Related Hair Transplant Cost UK 2025: NHS, Private Clinics vs At-Home Devices — Article 017 →What to Actually Say at Your GP Appointment
If you're going to a GP about hair loss, here's how to get the most out of a 10-minute consultation:
- Ask for blood tests first. Request ferritin, vitamin D, zinc, and TSH. Frame it as wanting to rule out correctable causes before starting pharmaceutical treatment. Most GPs will agree to this.
- Ask specifically about finasteride. Don't wait for it to be offered — ask directly. Your GP can prescribe it privately. If they're reluctant, ask about the evidence base and your candidacy based on your Norwood stage.
- Don't ask for an NHS dermatology referral for standard MPHL. It's unlikely to be granted and the wait is long. Private dermatology or a trichologist gives faster access to the specialist advice that MPHL at Norwood I–III benefits most from.
- Be specific about your timeline and stage. GPs are more likely to act proactively if you can say "I've noticed significant change in the last 18 months and I'm at Norwood II–III." Specificity signals seriousness and increases the quality of the response.
Male pattern hair loss follows a predictable biological progression. The follicles at Norwood I–II are miniaturised but active. At Norwood IV–V, many are dormant beyond reactivation. The difference between these outcomes is not genetics — it's when you started treating. The men who regret waiting aren't those who acted early and found it wasn't necessary. They're the ones who waited until it was obvious, then found the window had closed.
CAN'T PRESCRIBE.
£349 · CE certified · 90-day guarantee · Free UK delivery